For example, only a few polyphenol treatments altered serum adiponectin levels in NAFLD patients and healthy volunteers [45,57], which may be related to the difference between human and animal. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.